LEADER trial: difference between revisions
Diff·revision 15 → 16·16:18, 11 May 2025
Difference between revision 15 and revision 16 of LEADER trial. 1 line changed; the page grew by 29 bytes.
| Revision 15 — 10:16, 25 Apr 2025 DMF_Dermot (talk) the percentage quoted was placebo-adjusted; label it 3,537 bytes ±0 | Revision 16 — 16:18, 11 May 2025 DMF_Dermot (talk) rm the cross-trial comparison; the populations are not comparable 3,566 bytes +29 | ||
|---|---|---|---|
| 44 | * [[FLOW trial]] | 44 | * [[FLOW trial]] |
| 45 | * [[GLP-1 receptor agonist]] | 45 | * [[GLP-1 receptor agonist]] |
| + | 46 | * [[Number needed to treat]] | |
| 46 | 47 | ||
| 47 | {{DEFAULTSORT:LEADER trial}} | 48 | {{DEFAULTSORT:LEADER trial}} |